Literature DB >> 16198119

Evaluation of matrix effect and chromatography efficiency: new parameters for validation of method development.

Eduard Rogatsky1, Daniel Stein.   

Abstract

From the viewpoint of regulatory guidelines, validation of LC-UV and LC-MS based methods have the same requirements. Matrix effects are not considered for most method validations if they do not influence reproducibility or assay linearity. Since matrix effects can strongly suppress ionizaton efficiency and therefore reduce sensitivity, they must be evaluated (and discussed in the context of method development)--prior to method qualification. The severity of matrix effects is directly dependent upon chromatographic performance. We suggest that evaluation of matrix effects and LC efficiency is essential information for method assessment, optimization and transfer to other mass spectrometers, and should be a mandatory part of routine LC/MS method validation.

Mesh:

Year:  2005        PMID: 16198119     DOI: 10.1016/j.jasms.2005.07.012

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  11 in total

1.  Alternative calibration approaches to compensate the effect of co-extracted matrix components in liquid chromatography-electrospray ionisation tandem mass spectrometry analysis of pesticide residues in plant materials.

Authors:  Jitka Zrostlíková; Jana Hajslová; Jan Poustka; Pavel Begany
Journal:  J Chromatogr A       Date:  2002-10-11       Impact factor: 4.759

2.  Quantitative characterization of differential ion suppression on liquid chromatography/atmospheric pressure ionization mass spectrometric bioanalytical methods.

Authors:  Michael J Avery
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

3.  Application of the standard addition approach for the quantification of urinary benzene.

Authors:  Pascale Basilicata; Nadia Miraglia; Maria Pieri; Antonio Acampora; Leonardo Soleo; Nicola Sannolo
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-04-25       Impact factor: 3.205

Review 4.  Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

Authors:  Paul J Taylor
Journal:  Clin Biochem       Date:  2005-04       Impact factor: 3.281

5.  The ECHO technique--the more effective way of data evaluation in liquid chromatography-tandem mass spectrometry analysis.

Authors:  Lutz Alder; Sonja Lüderitz; Karen Lindtner; Hans-Jürgen Stan
Journal:  J Chromatogr A       Date:  2004-11-26       Impact factor: 4.759

6.  Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures.

Authors:  Sandrine Souverain; Serge Rudaz; Jean-Luc Veuthey
Journal:  J Chromatogr A       Date:  2004-11-26       Impact factor: 4.759

7.  The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds.

Authors: 
Journal:  Rapid Commun Mass Spectrom       Date:  1999-06       Impact factor: 2.419

8.  Comparison of SPE and fast LC to eliminate mass spectrometric matrix effects from microsomal incubation products.

Authors:  Joanna J Zheng; Eric D Lynch; Steve E Unger
Journal:  J Pharm Biomed Anal       Date:  2002-04-15       Impact factor: 3.935

9.  Evaluation of three calibration methods to compensate matrix effects in environmental analysis with LC-ESI-MS.

Authors:  Markus Stüber; Thorsten Reemtsma
Journal:  Anal Bioanal Chem       Date:  2003-12-20       Impact factor: 4.142

10.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid.

Authors:  Riet Dams; Marilyn A Huestis; Willy E Lambert; Constance M Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

View more
  6 in total

1.  Labeled content of two furanocoumarins in dietary supplements correlates with neither actual content nor CYP3A inhibitory activity.

Authors:  Karen M VanderMolen; Garrett R Ainslie; Mary F Paine; Nicholas H Oberlies
Journal:  J Pharm Biomed Anal       Date:  2014-06-02       Impact factor: 3.935

2.  Orthogonal Comparison of GC-MS and 1H NMR Spectroscopy for Short Chain Fatty Acid Quantitation.

Authors:  Jingwei Cai; Jingtao Zhang; Yuan Tian; Limin Zhang; Emmanuel Hatzakis; Kristopher W Krausz; Philip B Smith; Frank J Gonzalez; Andrew D Patterson
Journal:  Anal Chem       Date:  2017-07-12       Impact factor: 6.986

3.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

4.  Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer.

Authors:  Keefe Murphy; Brendan T Murphy; Susie Boyce; Louise Flynn; Sarah Gilgunn; Colm J O'Rourke; Cathy Rooney; Henning Stöckmann; Anna L Walsh; Stephen Finn; Richard J O'Kennedy; John O'Leary; Stephen R Pennington; Antoinette S Perry; Pauline M Rudd; Radka Saldova; Orla Sheils; Denis C Shields; R William Watson
Journal:  Mol Oncol       Date:  2018-08-07       Impact factor: 6.603

5.  Quick Multi-Class Determination of Residues of Antimicrobial Veterinary Drugs in Animal Muscle by LC-MS/MS.

Authors:  Meiyu Zhang; Erfen Li; Yijuan Su; Yingxia Zhang; Jingmeng Xie; Limin He
Journal:  Molecules       Date:  2018-07-16       Impact factor: 4.411

6.  Development, Validation, and Application of the UPLC-DAD Methodology for the Evaluation of the Qualitative and Quantitative Composition of Phenolic Compounds in the Fruit of American Cranberry (Vaccinium macrocarpon Aiton).

Authors:  Rima Urbstaite; Lina Raudone; Mindaugas Liaudanskas; Valdimaras Janulis
Journal:  Molecules       Date:  2022-01-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.